HealthDay News — A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care for some of the most vulnerable children. The medicine, called Coartem ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants ...

In addition, healthcare professionals may regard penicillins, cephalosporins, and other antibiotics as subclasses of beta-lactam drugs.

Health Care Drug compounders sue over weight loss drugs’ removal from FDA shortage list by Joseph Choi - 02/25/25 4:46 PM ET Andrew Harnik, Associated Press file ...

NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications.

CMS is looking to further refine its new Medicare $2 Drug List Model to make prices more predictable for Part D beneficiaries.

The proposed Medicare High-Value Drug List Model, also known as the Medicare $2 Drug List, could have modestly reduced out-of-pocket costs for 38% of beneficiaries if implemented in 2021.

Of particular concern are third-generation cephalosporin-resistant Enterobacterales, which resist a group of antimicrobial compounds that had been a good option for treating bacteria with evolved ...

Orchid Pharma blossoms with new blockbuster drug The pharma company’s India-discovered drug Enmetazobactum, the first to receive US FDA approval, will help it flower with strength ...